how safe are glp-1 drugs There has been a drug safety update from Medicines and Healthcare products Regulatory Agency (MHRA) for healthcare professionals FDA warns about unapproved GLP-1

In June 2024, researchers at Childrens Hospital of Philadelphia (CHOP) revealed mechanisms behind a molecules role in regulating insulin sensitivity, potentially paving the way for a new therapeutic target for obesity-related type 2 diabetes

Scientists now recognize that aging reflects a set of measurable biological processes that influence how cells respond to stress, repair damage, and maintain normal function

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition

Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network

Discontinued and Phase-Out GLP-1 Medications Some GLP 1 products have been discontinued or phased out as newer formulations and improved delivery systems emerged